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In normal daily diet consisting of  52-55% 
carbohydrate, 32-34% fat, and 14-18% protein, a 
couple hours following meal and absorption there 
is abundant fuel supply particularly from glucose 
oxidation in most tissues (Kathleen M Botham and 
Mayes, 2015; USDA, 2015). Conversely, in ketosis 
condition, most tissues replace its energy requirement 
from glucose to ketone bodies resulting from hepatic 
ketogenesis (Cervenka and Kossoff, 2013; Mcdonald 
and Cervenka, 2017). In extra hepatic tissues, adenosine 
triphosphate (ATP) is synthesized through revert back of  
acetoacetate to acetoacetyl-CoA catalyzed by succinyl-
CoA-acetoacetate CoA transferase. By this reaction 
acetoacetyl-CoA is split into two acetyl-CoA catalyzed 
by thiolase and then inserted into Kreb’s cycle to form 
ATP. Acetoacetate and b hydroxybutyrate are also able to 
traverse blood brain barrier and metabolized by cellular 
brain into ATP and used as energy also postulated as 
anticonvulsant (Freeman et al., 2007; J. L. Gamble et al., 
1923). Moreover, when ketone bodies in circulation are 
increased, oxidation of  ketone bodies also raised until 
saturation of  the pathway is achieved at 12 mmol/L 
concentration (Kathleen M. Botham and Mayes, 2015). 
Concern to the energy synthesis, acetoacetate and 3-b 
hydroxybutyrate are the prominent ketone bodies which 
are readily oxidized in extra-hepatic tissues. Whilst 
acetone have not metabolic function and in large extent 
is volatilized through the lung marked by breathe odor 
(Kathleen M. Botham and Mayes, 2015; Paoli, 2014). 
Ketosis is also able to suppress hunger feeling and 
appetite, therefore potential to be a good regulator of  
the body’s calorie intake (Dashti et al., 2004).  However, 
ketosis which is induced by ketogenic diet (KD), in the 
long term, its safety, morbidity, and mortality remain 
inconclusive. 
The ketogenic diet (KD) is a type of  diet 
characterized by high-fat, low-carbohydrate, and 
adequate protein (Freeman et al., 2007; Hemingway 
et al., 2001).  The amount intake of  fat in classical KD 
is up to 90%, carbohydrate 2%, and protein 8% (4:1) 
per day. In order to increase flexibility, palatability, and 
adherence of  patients on KD, several variants were 
emerged in lower ratio such as modified Atkins diet 
and Cervenka, 2017; Ye et al., 2015). Ketogenic diet 
is proposed mimic fasting and starvation state. In this 
condition, glucose and the body’s glycogen reserve 
is very limited, therefore lipid metabolism through b 
oxidation is activated yielding acetyl-CoA and hence 
hepatic ketogenesis. Ketone bodies are synthesized from 
condensation of two acetyl-CoA located in mitochondria 
catalyzed by thiolase to form acetoacetyl-CoA (Kathleen 
M. Botham and Mayes, 2015). Moreover, acetoacetyl-
CoA react with another acetyl-CoA to forms 3-hydroxy-
3-methylglutaryl-CoA (HMG-CoA) catalyzed by HMG-
CoA synthase. Furthermore, HMG-CoA is split off  by 
HMG-CoA lyase yielding free acetoacetate (Kathleen 
M Botham and Mayes, 2015; Paoli, 2014). Subsequently, 
acetoacetate is converted to 3-b hydroxybutyrate 
catalyzed by 3-hydroxybutyrate dehydrogenase or 
vice versa (Paoli, 2014). In addition, acetoacetate 
also undergo spontaneously decarboxylation resulting 
acetone. Consequently, concentration of  ketone bodies 
in circulation increased, namely ketonemia, followed by 
elevation of  ketone bodies in urine namely ketonuria. 
Both ketonemia and ketonuria is called ketosis (Kathleen 
M Botham and Mayes, 2015). This ketosis is called 
physiological ketosis, considering the concentration 
of  ketone bodies in well fed not exceed 0.02 mmol/L 
and pH remain neutral in 7.4 (Kathleen M. Botham 
and Mayes, 2015; Paoli, 2014). 
Ketogenic diet was firstly developed in 1920 and 
addressed to overcome the epilepsy seizure in children 
(Freeman et al., 2007). In year 1921, the efficacy of  KD 
on epilepsy was based on the postulate made by Wilder 
RM from Mayo Clinic suggested that metabolic effect 
of  starvation could be induced by a diet containing 
high in fat, low in carbohydrate, and in adequate 
protein (Freeman et al., 2007; Wilder R. M., 1921). 
The effectiveness of  KD as an anticonvulsant therapy 
on epilepsy constantly appeared until 1938, in which the 
new anticonvulsant phenytoin (Dilantin) was coined; 
thereby the effectiveness of  KD as anticonvulsant no 
more accepted (Wheless, 1995). However, in late 1980s, 
based on Kinsman’s review on 58 patients indicated 
that although the sufferer from epilepsy use of  many 
new anticonvulsant medications, including phenytoin, 
nevertheless KD remain demonstrated the same success 
rate with new anticonvulsant in refractory epilepsy 
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consisting of  fat 65%, protein 30%, and carbohydrate 
5% (3:1) per day (Lafountain et al., 2019; Mcdonald 
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(Kinsman et al., 1992). Some studies also showed that 
KD was capable of  reducing seizure particularly to 
intractable seizure that refractory to multiple treatments 
(Freeman et al., 2007; Martin-McGill et al., 2018; 
Mcdonald and Cervenka, 2017). Lastly, a systematic 
review from Cochrane on KD, concluded that KD in 
children have short to medium term efficacy in seizure 
control, even the effects of  which are comparable to 
modern antiepileptic drugs, however, many children 
intolerant to this diet (Levy et al., 2015).
Recently, KD also addresses to patients with 
adult onset epilepsy refractory to anticonvulsant or 
wish to limit anticonvulsant due to its adverse effect 
(Mcdonald and Cervenka, 2017). A study was reported 
by Hemingway C, et al., showed that following 3-6 
years initiating KD 20 (13%) patients had seizure free 
29 (14%), reducing seizure until 90-99%, and 29 of  150 
patients free of  medication (Hemingway et al., 2001). 
In addition, a meta analysis was published by Ye F, et al. 
demonstrated that classical KD have overall efficacy of  
42%, constituting a promising complementary therapy 
in adult intractable epilepsy, however, the adherence 
rate was relatively low (Ye et al., 2015). Another review 
was reported by Payne NE suggested that classical KD 
was able to reduce seizure frequency more than 50% 
upon 49% of  206 patients, even 13% of  these were 
seizure free (Payne et al., 2011). 
Nowadays, KD is addressed to reduce body 
weight in obese people (Hemingway et al., 2001; 
Lafountain et al., 2019). It is plausible, since various 
evidences indicated that KD was able to reduce body 
fat rapidly. Other evidences also pointed out that KD 
was effective at least in the short to medium term to 
lose weight, hyperlipidemia, and some cardiovascular 
risk (Paoli, 2014). A study was reported by Dashti HM, 
et al., suggested that KD was able to decrease body 
weight, body mass index (BMI), LDL, triglyceride, 
glucose, and conversely increase HDL concentration 
significantly in eight week (Dashti et al., 2004). 
Ketogenic diet in this study contains 40-50 gram 
carbohydrate and completely micronutrient was also 
given. Trace elements supplementations were necessary, 
since some evidences indicated that children on KD 
maintenance more than two years experience deficient 
several micronutrients (Wheless, 2001). Related to LDL, 
this study was contradictory to the study was reported 
by Hernandez TL, et al. demonstrated that LDL and 
free fatty acid (FFA) concentration were elevated in 
KD (Hernandez et al., 2010). Moreover, KD had also 
been proven capable of  reversing metabolic syndrome 
and type 2 diabetes mellitus. A study was reported by 
Volek JS, et al indicated that KD consisting of  59% 
fat, 12% carbohydrate, and 28% protein in 40 samples 
with atherogenic dyslipidemia were more consistent in 
improvement of  metabolic syndrome marker compared 
to that of  low fat diet consisting of  56% carbohydrate, 
24% fat, and 20% protein, albeit both of  diets were 
capable of  improving marker of  metabolic syndrome 
(Volek et al., 2009, 2008). Another study was done 
by Hallberg SJ, et al. showed that nutritional ketosis 
approach on type 2 diabetes mellitus characterized 
by 0.5–3.0 mmol/L of  b hydroxybutyrate capable of  
reducing HbA1c, medication, and body weigh within 
70 days and can be maintained in one year afterward 
(Hallberg et al., 2018). The weakness of  this study 
did not measure the mortality rate due to insufficient 
time duration. 
Based on aforementioned data, KD or low 
carbohydrate diet in short term appear beneficial in 
refractory epilepsy, reduction of  body weight, reversing 
metabolic syndrome, and type 2 diabetes. However, in 
the long term safety of  KD and low carbohydrate diet 
remain unclear owing to some adverse effect during 
experience KD such as trace element and vitamin D 
deficiency, kidney stone, dyslipidemia, prolong QT 
interval, optic neuropathy, lethargy, even premature 
death (Mazidi et al., 2019; Wheless, 2001). A critically 
appraised on randomized control trial and meta-analysis 
was done by Manikam et al. demonstrated that short 
term and long term of KD poses adverse effect in increase 
of  cardiovascular disease due to the reduction of  flow-
mediated dilatation of  brachial artery (Manikam et al., 
2018). It was plausible, since atherosclerosis can be 
induced by the increase in plasma free fatty acid caused 
by high fat diet (Kathleen M Botham and Mayes, 2015). 
This statement was supported by Hernandez’s study 
showed that in high fat diet during 6 week had been 
proven capable of  increasing LDL and FFA plasma 
(Hernandez et al., 2010). Elevation of  LDL and FFA 
concentration particularly palmitic acid in plasma will 
induce endothelial dysfunction and atherosclerosis 
(Ghosh et al., 2017). Furthermore, A prospective study 
was published by Mazidi M, et al. suggested that low 
carbohydrate diet had the highest mortality rate of  
cardiovascular disease, cerebrovascular, and cancer. The 
relation between low carbohydrate diet and mortality 
rate was stronger in non-obese compared to that of  
obese subjects (Mazidi et al., 2019). Another prospective 
study and meta-analysis also demonstrated that during 
25 years follow up on 15.428 adults aged 45–64 years; 
the increment of  mortality rate was associated with both 
low and high percentage of  carbohydrate diets, with the 
lowest mortality rate observed in 50% (Seidelmann et al., 
2018). Accordingly, to reduce body weight particularly 
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in subject with overweight and obese, reduction of  50% 
carbohydrate in daily diet is the rational choice.  
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